Loxo Oncology to Present at Upcoming Investor Conferences
September 01 2016 - 6:45AM
Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company
innovating the development of highly selective medicines for
patients with genetically defined cancers, today announced
that the company will be participating in the following
upcoming investor conferences:
- At the Citi Annual Biotech Conference on September 8,
2016 at 8:00AM ET in Boston, Joshua H.
Bilenker, M.D., chief executive officer, will
be participating in a panel discussion entitled, “Developing Cancer
Therapeutics in 2016”
- At the Morgan Stanley Global Healthcare Conference
on September 14, 2016 at 2:10PM ET in New York City, Joshua H.
Bilenker, M.D., chief executive officer, will present a corporate
overview
Live webcasts of the panel and presentation will be available
at http://ir.loxooncology.com/.
About Loxo Oncology Loxo Oncology is
a biopharmaceutical company innovating the development of highly
selective medicines for patients with genetically defined cancers.
Our pipeline focuses on cancers that are uniquely dependent on
single gene abnormalities, such that a single drug has the
potential to treat the cancer with dramatic effect. We believe that
the most selective, purpose-built medicines have the highest
probability of maximally inhibiting the intended target, thereby
delivering best-in-class disease control and safety. Our management
team seeks out experienced industry partners, world-class
scientific advisors and innovative clinical-regulatory approaches
to deliver new cancer therapies to patients as quickly and
efficiently as possible. For more information, please visit the
company's website at www.loxooncology.com.
Contacts for Loxo Oncology, Inc.
Company:Jacob S. Van NaardenChief Business
Officerjake@loxooncology.com
Investors:Peter RahmerThe Trout Group,
LLC646-378-2973prahmer@troutgroup.com
Media:Dan BudwickPure Communications,
Inc.973-271-6085dan@purecommunicationsinc.com
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Aug 2024 to Sep 2024
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Sep 2023 to Sep 2024